Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's Disease
NCT02906488 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 839
Last updated 2025-08-24
Summary
The purpose of this study is to assess the safety and efficacy of long-term use of Duodopa in patients with Parkinkon's disease in actual usage
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
ABBVIE INC. · AbbVie
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-09-12
- Primary Completion
- 2025-07-24
- Completion
- 2025-07-24
Countries
- Japan
Study Locations
More Related Trials
-
Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease
NCT02469090 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Japanese Participants With Parkinson's Disease
NCT03716570 ·Status: TERMINATED ·Phase: PHASE1
-
A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients
NCT01628848 ·Status: COMPLETED ·Phase: PHASE2
-
EMD 128130 for the Treatment of Parkinson's Disease
NCT00009048 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study of Subcutaneous Infusion of ABBV-951 to Assess Change in Disease Activity and Adverse Events In Adult Japanese Participants With Advanced Parkinson's Disease
NCT05916157 ·Status: ACTIVE_NOT_RECRUITING
-
A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.
NCT03845387 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's Disease
NCT00006077 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease
NCT00558337 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of MK0657 in Parkinson's Disease Patients (0657-006)
NCT00505843 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease
NCT03068481 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease
NCT00219284 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease
NCT06055985 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Biomarker Study of PTC-589 in Participants With Parkinson's Disease
NCT02462603 ·Status: COMPLETED ·Phase: PHASE2
-
A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease
NCT06722729 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
NCT00660387 ·Status: COMPLETED ·Phase: PHASE3
-
Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia
NCT00314288 ·Status: COMPLETED ·Phase: PHASE2
-
Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects
NCT00360568 ·Status: COMPLETED ·Phase: PHASE3
-
NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa
NCT05083260 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
NCT00357994 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2a Study Followed to Evaluate the Safety, Tolerability and Levodopa Pharmacokinetics in Levodopa-treated Parkinson's Disease Patients Receiving ND0612
NCT01883505 ·Status: COMPLETED ·Phase: PHASE2
-
Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease
NCT04380142 ·Status: COMPLETED ·Phase: PHASE3
-
Nilotinib in Parkinson's Disease
NCT03205488 ·Status: COMPLETED ·Phase: PHASE2
-
An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medications
NCT02082249 ·Status: COMPLETED ·Phase: PHASE3
-
Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off
NCT00642356 ·Status: TERMINATED ·Phase: PHASE4
-
The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
NCT00286897 ·Status: COMPLETED ·Phase: PHASE3